Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Biol ; 22(1): 14, 2024 Jan 25.
Article in English | MEDLINE | ID: mdl-38273313

ABSTRACT

BACKGROUND: Mosquito borne viruses, such as dengue, Zika, yellow fever and Chikungunya, cause millions of infections every year. These viruses are mostly transmitted by two urban-adapted mosquito species, Aedes aegypti and Aedes albopictus. Although mechanistic understanding remains largely unknown, Aedes mosquitoes may have unique adaptations that lower the impact of viral infection. Recently, we reported the identification of an Aedes specific double-stranded RNA binding protein (dsRBP), named Loqs2, that is involved in the control of infection by dengue and Zika viruses in mosquitoes. Preliminary analyses suggested that the loqs2 gene is a paralog of loquacious (loqs) and r2d2, two co-factors of the RNA interference (RNAi) pathway, a major antiviral mechanism in insects. RESULTS: Here we analyzed the origin and evolution of loqs2. Our data suggest that loqs2 originated from two independent duplications of the first double-stranded RNA binding domain of loqs that occurred before the origin of the Aedes Stegomyia subgenus, around 31 million years ago. We show that the loqs2 gene is evolving under relaxed purifying selection at a faster pace than loqs, with evidence of neofunctionalization driven by positive selection. Accordingly, we observed that Loqs2 is localized mainly in the nucleus, different from R2D2 and both isoforms of Loqs that are cytoplasmic. In contrast to r2d2 and loqs, loqs2 expression is stage- and tissue-specific, restricted mostly to reproductive tissues in adult Ae. aegypti and Ae. albopictus. Transgenic mosquitoes engineered to express loqs2 ubiquitously undergo developmental arrest at larval stages that correlates with massive dysregulation of gene expression without major effects on microRNAs or other endogenous small RNAs, classically associated with RNA interference. CONCLUSIONS: Our results uncover the peculiar origin and neofunctionalization of loqs2 driven by positive selection. This study shows an example of unique adaptations in Aedes mosquitoes that could ultimately help explain their effectiveness as virus vectors.


Subject(s)
Aedes , Dengue , Zika Virus Infection , Zika Virus , Animals , Aedes/genetics , Carrier Proteins/genetics , Mosquito Vectors/genetics , RNA, Double-Stranded/genetics , RNA, Double-Stranded/metabolism , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism , Zika Virus/genetics , Zika Virus/metabolism
2.
Nat Microbiol ; 3(12): 1385-1393, 2018 12.
Article in English | MEDLINE | ID: mdl-30374169

ABSTRACT

Dengue virus (DENV) is an arbovirus transmitted to humans by Aedes mosquitoes1. In the insect vector, the small interfering RNA (siRNA) pathway is an important antiviral mechanism against DENV2-5. However, it remains unclear when and where the siRNA pathway acts during the virus cycle. Here, we show that the siRNA pathway fails to efficiently silence DENV in the midgut of Aedes aegypti although it is essential to restrict systemic replication. Accumulation of DENV-derived siRNAs in the midgut reveals that impaired silencing results from a defect downstream of small RNA biogenesis. Notably, silencing triggered by endogenous and exogenous dsRNAs remained effective in the midgut where known components of the siRNA pathway, including the double-stranded RNA (dsRNA)-binding proteins Loquacious and r2d2, had normal expression levels. We identified an Aedes-specific paralogue of loquacious and r2d2, hereafter named loqs2, which is not expressed in the midgut. Loqs2 interacts with Loquacious and r2d2 and is required to control systemic replication of DENV and also Zika virus. Furthermore, ectopic expression of Loqs2 in the midgut of transgenic mosquitoes is sufficient to restrict DENV replication and dissemination. Together, our data reveal a mechanism of tissue-specific regulation of the mosquito siRNA pathway controlled by Loqs2.


Subject(s)
Aedes/metabolism , Carrier Proteins/metabolism , Dengue Virus/metabolism , Ectopic Gene Expression , RNA, Double-Stranded/metabolism , RNA, Small Interfering/metabolism , RNA-Binding Proteins/metabolism , Aedes/genetics , Aedes/virology , Animals , Animals, Genetically Modified , Antiviral Agents/metabolism , Antiviral Agents/pharmacology , Carrier Proteins/genetics , DNA Replication , Dengue/virology , Dengue Virus/drug effects , Dengue Virus/genetics , Dengue Virus/pathogenicity , Drosophila Proteins , Female , Gastrointestinal Tract/virology , Gene Silencing , Host-Pathogen Interactions , Mosquito Vectors/virology , RNA, Viral/metabolism , RNA-Binding Proteins/genetics , RNA-Binding Proteins/pharmacology , Virus Replication , Zika Virus/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...